Work-related Experiences and Unmet Needs of Patients with a Malignant Glioma and Relevant Professionals: the BrainWork Study

Overview

Journal J Cancer Surviv

Specialty Oncology

Date 2023 Oct 2

PMID 37782399

Authors

Amber Danielle Zegers

Pieter Coenen

Amy Heeren

Nadia Takke

Hilko Ardon

Annette Compter

Desiree Dona

Mathilde Kouwenhoven

Sanne B Schagen

Filip de Vos

Saskia F A Duijts

Affiliations

Soon will be listed here.

Abstract

Purpose: Many patients with a malignant (i.e., grade II-IV) glioma are of working age, yet they are rarely included in "cancer and work" studies. Here, we explored (1) the work-related experiences and unmet needs of patients with a malignant glioma and (2) the experiences and needs of relevant healthcare and occupational (health) professionals ("professionals") in providing work-related support to this patient group.

Methods: Individual semi-structured interviews were held with patients with a malignant glioma who were of working age and had an employment contract at diagnosis, and relevant professionals. Interviews were transcribed verbatim and analysed thematically.

Results: Patients (n = 22) were on average 46 ± 13 years of age (64% male) and diagnosed with a grade II (n = 12), III (n = 4), or IV glioma (n = 6). Professionals (n = 16) had on average 15 ± 9 years of relevant work experience with the patient group. Four themes emerged from the data: (1) having a malignant glioma: experienced consequences on work ability, (2) communicating about the consequences of a malignant glioma at work, (3) distilling the right approach: generic or tailored work-related support, and (4) accessibility of work-related support.

Conclusions: Glioma-specific consequences on patients' work ability necessitate better communication between, and tailored guidance for, patients, relevant professionals, and the workplace. Suggestions for improvement, e.g., the periodic use of comprehensive neuropsychological assessments, are provided in the article.

Implications For Cancer Survivors: Patients with a malignant glioma would benefit from tailored and proactive outreach about work-related issues bv relevant professionals.

Citing Articles

Group medical visits in cancer survivorship care: a scoping review.

Dixit N, Avilez L, Honcharov V, Knopf K, Bedi T, Nekhlyudov L J Cancer Surviv. 2024; .

PMID: 39557760 DOI: 10.1007/s11764-024-01662-8.

High costs, low quality of life, reduced survival, and room for improving treatment: an analysis of burden and unmet needs in glioma.

Pohlmann J, Weller M, Marcellusi A, Grabe-Heyne K, Krott-Coi L, Rabar S Front Oncol. 2024; 14:1368606.

PMID: 38571509 PMC: 10987841. DOI: 10.3389/fonc.2024.1368606.

References

van Loon E, Ernens W, Heijenbrok-Kal M, Horemans H, Ribbers G, van den Bent M . Long-term employment status and the association with fatigue in patients with grade II glioma. J Rehabil Med. 2021; 53(5):jrm00198. PMC: 8814885. DOI: 10.2340/16501977-2837. View

Larjavaara S, Mantyla R, Salminen T, Haapasalo H, Raitanen J, Jaaskelainen J . Incidence of gliomas by anatomic location. Neuro Oncol. 2007; 9(3):319-25. PMC: 1907421. DOI: 10.1215/15228517-2007-016. View

Tanzilli A, Pace A, Prosperini L, Oppido P, Telera S, Rasile F . Multidomain and long-term cognitive evaluation in malignant glioma patients. Future Oncol. 2022; 18(15):1839-1848. DOI: 10.2217/fon-2021-0963. View

Schiavolin S, Mariniello A, Broggi M, Acerbi F, Schiariti M, Franzini A . Characteristics of Patients Returning to Work After Brain Tumor Surgery. Front Hum Neurosci. 2021; 14:609080. PMC: 7886680. DOI: 10.3389/fnhum.2020.609080. View

Islam T, Dahlui M, Majid H, Nahar A, Taib N, Su T . Factors associated with return to work of breast cancer survivors: a systematic review. BMC Public Health. 2014; 14 Suppl 3:S8. PMC: 4251139. DOI: 10.1186/1471-2458-14-S3-S8. View

Zhao K, Yu C, Gan Z, Huang M, Wu T, Zhao N . Rehabilitation therapy for patients with glioma: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2020; 99(45):e23087. PMC: 7647558. DOI: 10.1097/MD.0000000000023087. View

Boele F, Rooney A, Grant R, Klein M . Psychiatric symptoms in glioma patients: from diagnosis to management. Neuropsychiatr Dis Treat. 2015; 11:1413-20. PMC: 4467748. DOI: 10.2147/NDT.S65874. View

Hansen A, Pedersen C, Jarden J, Beier D, Minet L, Sogaard K . Effectiveness of Physical Therapy- and Occupational Therapy-Based Rehabilitation in People Who Have Glioma and Are Undergoing Active Anticancer Treatment: Single-Blind, Randomized Controlled Trial. Phys Ther. 2020; 100(3):564-574. DOI: 10.1093/ptj/pzz180. View

Zwinkels H, Dirven L, Vissers T, Habets E, Vos M, Reijneveld J . Prevalence of changes in personality and behavior in adult glioma patients: a systematic review. Neurooncol Pract. 2019; 3(4):222-231. PMC: 6657393. DOI: 10.1093/nop/npv040. View

10.

Zegers A, van Andel E, Beerda D, Dona D, Aukema E, Brom L . Work resumption and retention in patients with advanced cancer: Experiences and perspectives of general and occupational health care professionals. Eur J Cancer Care (Engl). 2022; 31(6):e13714. PMC: 9787025. DOI: 10.1111/ecc.13714. View

11.

Zegers A, Coenen P, Bultmann U, van Hummel R, van der Beek A, Duijts S . Tailoring work participation support for cancer survivors using the stages of change: perspectives of (health care) professionals and survivors. J Cancer Surviv. 2022; 17(3):706-719. PMC: 10209302. DOI: 10.1007/s11764-022-01196-x. View

12.

van Coevorden-van Loon E, Heijenbrok-Kal M, Horemans H, Boere R, de Bat R, Vincent A . The relationship between mental fatigue, cognitive functioning, and employment status in patients with low-grade glioma: a cross-sectional single-center study. Disabil Rehabil. 2021; 44(24):7413-7419. DOI: 10.1080/09638288.2021.1991013. View

13.

Boele F, Meads D, Jansen F, Verdonck-de Leeuw I, Heimans J, Reijneveld J . Healthcare utilization and productivity loss in glioma patients and family caregivers: the impact of treatable psychological symptoms. J Neurooncol. 2020; 147(2):485-494. PMC: 7136180. DOI: 10.1007/s11060-020-03454-3. View

14.

Donker-Cools B, Schouten M, Wind H, Frings-Dresen M . Return to work following acquired brain injury: the views of patients and employers. Disabil Rehabil. 2016; 40(2):185-191. DOI: 10.1080/09638288.2016.1250118. View

15.

IJzerman-Korevaar M, Snijders T, de Graeff A, Teunissen S, de Vos F . Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review. J Neurooncol. 2018; 140(3):485-496. PMC: 6267240. DOI: 10.1007/s11060-018-03015-9. View

16.

Torp S, Gudbergsson S, Dahl A, Fossa S, Flotten T . Social support at work and work changes among cancer survivors in Norway. Scand J Public Health. 2011; 39(6 Suppl):33-42. DOI: 10.1177/1403494810395827. View

17.

de Boer A, Taskila T, Ojajarvi A, van Dijk F, Verbeek J . Cancer survivors and unemployment: a meta-analysis and meta-regression. JAMA. 2009; 301(7):753-62. DOI: 10.1001/jama.2009.187. View

18.

Greidanus M, de Boer A, de Rijk A, Frings-Dresen M, Tamminga S . The MiLES intervention targeting employers to promote successful return to work of employees with cancer: design of a pilot randomised controlled trial. Trials. 2020; 21(1):363. PMC: 7189583. DOI: 10.1186/s13063-020-04288-0. View

19.

Dorland H, Abma F, Roelen C, Smink J, Ranchor A, Bultmann U . Factors influencing work functioning after cancer diagnosis: a focus group study with cancer survivors and occupational health professionals. Support Care Cancer. 2015; 24(1):261-266. PMC: 4669376. DOI: 10.1007/s00520-015-2764-z. View

20.

Nicklin E, Phang I, Short S, Hoogendoorn P, Boele F . Patient and caregiver return to work after a primary brain tumor. Neurooncol Pract. 2023; 10(6):565-575. PMC: 10666801. DOI: 10.1093/nop/npad039. View